title: Oral etoposide in the treatment of malignant mesothelioma. A phase II study.
authors.affiliation: Department of Epidemiology and Biostatistics, Institute of Occupational Health, Helsinki, Finland.
authors.forename: L
authors.initials: L
authors.lastname: Tammilehto
authors.forename: P
authors.initials: P
authors.lastname: Maasilta
authors.forename: M
authors.initials: M
authors.lastname: Mäntylä
authors.forename: J
authors.initials: J
authors.lastname: Salo
authors.forename: K
authors.initials: K
authors.lastname: Mattson
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy*; D008875:Middle Aged; D010534:Peritoneal Neoplasms / Q000188:drug therapy; D010997:Pleural Neoplasms / Q000188:drug therapy; D012074:Remission Induction
chemical_list: D005047:Etoposide